Symbols

NPCE

NeuroPace·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 4

Bearish signal 0

Consensus Rating "Buy"

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NPCE

Neuropace, Inc.

A commercial stage medical device company focused on solutions for epilepsy

Industry

Healthcare Equipment and Supplies

Established Date

11/19/1997

Listing Date

04/22/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

184

Fiscal Year Ends

12-31

Website

www.neuropace.com

Security Type

Common stock

Office address

455 N. Bernardo Avenue, Mountain View, CA 94043

Business

Introduction

NeuroPace, Inc., was incorporated in Delaware on November 19, 1997. The company is a medical device company focused on transforming the lives of people with epilepsy by reducing or eliminating the occurrence of debilitating seizures.

Earnings Call

Q1/2025

Estimate EPS-0.24

Actual EPS-0.21

Estimate Revenue21.85M

Actual Revenue22.50M

Navigating Contradictions: How Project CARE and Gross Margin Trends Shape RNS Growth in 2025

May 20,2025 11:39·
Earnings Decrypt

Q2/2025

Estimate EPS-0.22

Actual EPS-0.26

Estimate Revenue23.08M

Actual Revenue23.50M

NeuroPace's Q2 2025 Earnings Call: Unraveling Key Contradictions in Growth, Margins, and Strategy

Aug 12,2025 10:03·
Earnings Decrypt

Q3/2025

Estimate EPS-0.19

Actual EPS-0.11

Estimate Revenue24.63M

Actual Revenue27.40M

NeuroPace's Q3 2025: Contradictions Emerge on FDA Strategy, Growth Plans, Margins, and Market Expansion

Nov 04,2025 11:30·
Earnings Decrypt

Company Financials

EPS

NPCE has released its 2025 Q3 earnings. EPS was reported at -0.11, versus the expected -0.19, beating expectations. The chart below visualizes how NPCE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NPCE has released its 2025 Q3 earnings report, with revenue of 27.35M, reflecting a YoY change of 29.89%, and net profit of -3.50M, showing a YoY change of 35.88%. The Sankey diagram below clearly presents NPCE's revenue sources and cost distribution.